DCAT

Enzene will be at DCAT, engaging in meaningful discussions on biologics and biosimilars.

Connect with us to:

– Discuss development and manufacturing solutions for your biologic’s pipelines.

– Explore biosimilar licensing and partnership opportunities for global markets.

Book a meeting with the Enzene team at DCAT 2026 to learn how we can support your progress from development to commercialization.

Book a meeting

Fields marked with a * are required

    Date: March 23 – 26, 2026

    Location: New York

    DCAT

    The future begins now

    Your biologic deserves the most technologically advanced manufacturing process in the industry. And you deserve a new way to think about strategic partnership. Today is just the beginning.